Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-13-000533
Filing Date
2013-02-28
Accepted
2013-02-28 07:01:13
Documents
3
Period of Report
2013-02-28

Document Format Files

Seq Description Document Type Size
1 6-K zk1312703.htm 6-K 16079
2 PRESS RELEASE DATED FEBRUARY 28, 2013 exhibit_1.htm EX-99 18206
3 b.jpg GRAPHIC 6762
  Complete submission text file 0001178913-13-000533.txt   44812
Mailing Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450
Business Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 13649023
SIC: 2834 Pharmaceutical Preparations